Citazione APA

Ericsson, Å., Glah, D., Lorenzi, M., Jansen, J. P., & Fridhammar, A. (2018). Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes. PLoS One.

Stile di citazione Chicago

Ericsson, Åsa, Divina Glah, Maria Lorenzi, Jeroen P. Jansen, e Adam Fridhammar. "Cost-effectiveness of Liraglutide Versus Lixisenatide As Add-on Therapies to Basal Insulin in Type 2 Diabetes." PLoS One 2018.

Citazione MLA

Ericsson, Åsa, et al. "Cost-effectiveness of Liraglutide Versus Lixisenatide As Add-on Therapies to Basal Insulin in Type 2 Diabetes." PLoS One 2018.

Attenzione: Queste citazioni potrebbero non essere precise al 100%.